Skip to content
PeptideSport
RxION Health logo

Provider review

RxION Health review

By Derek Olsson ·

Its actual clinical entity is Beluga Health, P.A. — not RxION Health, its own brand name

Semaglutide is $99 a month, tirzepatide $183, both struck through from higher numbers, and both bundling a $75 consultation fee you do not get back. The clinic you actually contract with is Beluga Health, P.A., not RxION.

Price verified

Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

The verdict

RxION names Alok Kushwaha as Medical Director and advertises Internal Medicine and Obesity Medicine board certifications on its About page. Those credentials have not been independently verified here. Its actual clinical entity is disclosed in the fine print as 'Beluga Health, P.A.' — a different name from the brand marketed to consumers — and its LegitScript badge is a self-hosted static image rather than one served from LegitScript itself.

RxION Health isn't on any of our comparisons yet. The providers we compare in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see how semaglutide works for what the treatment does and does not do.

Alternatives to RxION Health

Other providers we work with. Compare prices before you sign up anywhere.

Who it is for, and who it is not

A good fit if

  • You want a named Medical Director and can independently confirm the advertised Internal Medicine and Obesity Medicine certifications and current state license
  • You're comfortable with a pay-only-if-approved structure covering the $75 consultation fee
  • You're not in New Jersey, Alaska, or Mississippi, where it's explicitly excluded

Look elsewhere if

  • You want the clinical entity you're contracting with to match the brand name on the site — it's actually Beluga Health, P.A., disclosed only in the legal fine print
  • You want to independently verify a LegitScript certification via a live-served seal — this one is a self-hosted static image
  • You want a single, consistent business address — two different addresses appear across separate legal and contact pages

What it actually costs

What they advertise

Semaglutide 'starting at $99/month' (from a $199 base), tirzepatide 'starting at $183/month' (from $299), microdose GLP-1 'starting at $149/month' (from $199) — bundling a $75 non-refundable consultation fee plus medication.

What you actually pay, month to month

$99/month (semaglutide), $183/month (tirzepatide), or $149/month (microdose) at the promotional rate; the $75 consultation fee is refundable only if you're not approved.

The commitment trap

The strikethrough 'from $199/$299' figures are the pre-promotion list price, not a discount off a currently-charged rate — the promotional price is what's actually billed.

Money you will meet later

  • A $75 non-refundable consultation fee is bundled into the advertised price

Prices come from RxION Health's own website and can change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.

What is included

Compare the total cost, including fees and any minimum commitment. Here is what RxION Health bundles in, and what it does not.

Clinician consult

The About page names Alok Kushwaha, MD, as Medical Director

It does not identify the clinician assigned to every consultation. Confirm your treating clinician, current state license and any advertised board certification; NPI enumeration does not verify these.

Bloodwork / labs

Not published

Follow-ups and dose changes

No cadence published

Human support

Not published

Injection supplies

Not published

Shipping

Not published

Pharmacy, labs and oversight

The pharmacy

The Pharmacy Hub, named only in its Telemedicine Consent legal document, not on marketing pages.

Oversight

No cadence published.

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.

Where you can get it

Excluded for residents of New Jersey, Alaska, and Mississippi on every product page; otherwise not further specified.

The honest cons

The part they would rather you skipped

RxION Health's actual clinical-services entity, disclosed in its own Telemedicine Consent document, is 'Beluga Health, P.A.,' — a different legal name from the RxION brand marketed to consumers.

  • Actual clinical entity (Beluga Health, P.A.) is a different name from the consumer-facing RxION brand
  • LegitScript badge is a self-hosted static image, not a live-served seal from LegitScript itself
  • Two different business addresses appear across separate legal and contact pages
  • Named pharmacy partner appears only in legal fine print, not on marketing pages

Weigh these trade-offs against the costs, care and terms above. For questions to ask before enrolling, see our vendor red-flags guide.

Similar providers

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Provider offers and terms are based on RxION Health's public information. Other sources, where used, are identified in this review. Prices and terms change without notice — confirm on RxION Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.